Tris(1,1-dimethylethyl)phosphine → HCID 25006740, compound
Reaction equation
Br[C:2]1[C:7]([F:8])=[CH:6][C:5]([S:9]([NH:12][CH:13]2[CH2:15][CH2:14]2)(=[O:11])=[O:10])=[C:4]([F:16])[CH:3]=1.[C:17]([C:19]1[N:23]([CH3:24])[C:22](B(O)O)=[CH:21][CH:20]=1)#[N:18].[F-].[K+].C(P(C(C)(C)C)C(C)(C)C)(C)(C)C>C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[C:17]([C:19]1[N:23]([CH3:24])[C:22]([C:2]2[C:7]([F:8])=[CH:6][C:5]([S:9]([NH:12][CH:13]3[CH2:15][CH2:14]3)(=[O:11])=[O:10])=[C:4]([F:16])[CH:3]=2)=[CH:21][CH:20]=1)#[N:18]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
According to general procedure B, 4-bromo-N-cyclopropyl-2,5-difluorobenzenesulfonamide (150 mg, 0.5 mmol), 5-cyano-1-methyl-1H-pyrrol-2-ylboronic acid (90 mg, 0.60 mmol), potassium fluoride (96 mg, 1.65 mmol), and tris(dibenzylideneacetone)dipalladium (12 mg, 0.013 mmol) were placed in an oven dried flask under nitrogen and dry THF (1.3 mL) was added. Tri-t-butylphosphine (75 μL, 0.026 mmol, 10 wt % in hexane) was added and the reaction was stirred for 16 hours. Purification afforded 4-(5-cyano-1-methyl-1H-pyrrol-2-yl)-N-cyclopropyl-2,5-difluorobenzenesulfonamide (33 mg) HPLC purity 99.0% at 210-370 nm, 9.1 min.; the Xterra® RP18 column, 3.5μ, 150×4.6 mm column, 1.2 mL/min., 85/15-5/95 (ammonium formate buffer pH=3.5/ACN+MeOH) for 10 min., hold 4 min. HRMS: calcd for C15H13F2N3O2S−H+, 336.06238; found (ESI-FTMS, [M−H]1−), 336.06247
Workup
- customwere placed in an oven
- customdried flask under nitrogen
- additiondry THF (1.3 mL) was added
- customPurification
Sources & evidence
- ORD record
- ord-067dbe9d140449e2881100b81c5ac700
- Source dataset
- uspto-grants-2010_05
- Patent number
- US07723332B2
Reaction notes
Loading…